ORIC Earnings

Quarterly EPS
$-0.49
Q3 2024
$-0.51
Q4 2024
$-0.42
Q1 2025
$-0.47
Q2 2025
$-0.33
Q3 2025
$-0.30
Q4 2025
$-0.34
Q1 2026
$-0.38
Q2 2026
Latest RevenueN/A
Latest Net Income-41492000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.380-41492000+19.1%
Q1 2026-$0.340-35767000+19.0%
Q4 2025-$0.300-30505000+41.2%
Q3 2025-$0.330-32587000+32.7%
Q2 2025-$0.470-36355000-4.4%
Q1 2025-$0.420-30021000-13.5%
Q4 2024-$0.510-36307000-4.1%
Q3 2024-$0.490-34566000-11.4%
Q2 2024-$0.450-31963000
Q1 2024-$0.370-25011000
Q4 2023-$0.490-28330000
Q3 2023-$0.440-25478000
Oric Pharmaceuticals (ORIC) — Earnings